Influence of cladribine alone and in combination with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia.
Szmigielska-Kapłon
Anna
A
Jesionek-Kupnicka
Dorota
D
Góra-Tybor
Joanna
J
Błonski
Jerzy Z
JZ
Lech-Marańda
Ewa
E
Kordek
Radzisław
R
Kasznicki
Marek
M
Robak
Tadeusz
T
D000328:Adult; D000368:Aged; D001854:Bone Marrow Cells / Q000187:drug effects* / Q000473:pathology; D017338:Cladribine / Q000008:administration & dosage* / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008833:Microcirculation; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage*; D009389:Neovascularization, Pathologic; D016896:Treatment Outcome
D017338:Cladribine; D003520:Cyclophosphamide; D008942:Mitoxantrone